Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents

Gian Maria Rossolini1, Elisabetta Mantengoli, Francesca Montagnani

  • 1Department of Molecular Biology, Section of Microbiology, University of Siena, Viale Bracci 16, I-53100 Siena, Italy. rossolini@unisi.it

Insights

Gram-positive pathogens like MRSA are developing antibiotic resistance through mutations and gene transfer. Emerging linezolid resistance in Staphylococcus aureus is a growing concern, alongside increased Clostridium difficile infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Gram-positive pathogens cause significant community and hospital-acquired infections.
  • Antibiotic resistance in Gram-positive bacteria, including MRSA, GRE, and resistant pneumococci, poses major global health challenges.
  • Mechanisms of resistance involve mutations and horizontal gene transfer via mobile genetic elements.

Purpose of the Study:

  • To review the current landscape of antibiotic resistance in Gram-positive pathogens.
  • To highlight emerging resistance mechanisms and their clinical implications.
  • To discuss the association between antibiotic resistance and Clostridium difficile infections.

Main Methods:

  • Literature review of antibiotic resistance mechanisms in Gram-positive bacteria.
  • Analysis of clinical impact and dissemination of resistant strains.
  • Examination of emerging resistance trends to newer antibiotics.

Main Results:

  • Methicillin-resistant Staphylococcus aureus (MRSA), glycopeptide-resistant enterococci (GRE), and multidrug-resistant pneumococci are key resistance challenges.
  • Resistance to glycopeptides in staphylococci is uncommon; resistance to newer agents like linezolid, daptomycin, and tigecycline is rare but emerging.
  • A transferable linezolid resistance mechanism (Cfr protein) in S. aureus is a significant concern, with increasing reports in enterococci and coagulase-negative staphylococci.
  • Antibiotic resistance is linked to the rise of hypervirulent Clostridium difficile infection (CDI) strains.

Conclusions:

  • Gram-positive bacteria possess diverse mechanisms for antibiotic resistance evolution.
  • Emerging resistance to linezolid, particularly transferable mechanisms, requires urgent attention.
  • The interplay between antibiotic resistance and the increasing incidence of CDI warrants further investigation.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...